BioElectronics Corporation
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BIEL research report →
Companywww.bielcorp.com
BioElectronics Corporation, an electroceutical company, engages in the development and sale of wearable, neuromodulation devices to mitigate neurological diseases and enhance quality of life worldwide. Its products include ActiPatch, a musculoskeletal pain therapy; Allay, a menstrual pain therapy; and Smart Insole, a heel pain therapy. The company also offers RecoveryRx, a medical device that provides pain management therapy for medical professionals; and HealFast, a drug-free therapy for horses, cats, and dogs that reduces swelling and pain, as well as heals muscle and tendon injuries, sores, and incisions.
- CEO
- Kelly A. Whelan
- IPO
- 2004
- Employees
- 9
- HQ
- Frederick, MD, US
Price Chart
Valuation
- Market Cap
- $7.23M
- P/E
- -10.62
- P/S
- 14.58
- P/B
- -0.57
- EV/EBITDA
- -57.95
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 73.32%
- Op Margin
- -79.17%
- Net Margin
- -187.62%
- ROE
- 5.49%
- ROIC
- 20.93%
Growth & Income
- Revenue
- $496.03K · -30.60%
- Net Income
- $-930,650 · -28.75%
- EPS
- $0.00 · 0.00%
- Op Income
- $-392,689
- FCF YoY
- 51.14%
Performance & Tape
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 2.07
- Avg Volume
- 16.59M
Get TickerSpark's AI analysis on BIEL
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our BIEL Coverage
We haven't published any research on BIEL yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate BIEL Report →